Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07632742 · ClinicalTrials.gov registry record · NA
Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
A NA study, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT07632742: Recruiting NA study, sponsored by Northwestern University.
NCT07632742 is a NA study that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07632742, a NA study, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
Primary Outcome
Overall intraoperative hemostasis time
Interventions
- DEVICE Magneto 150 holmium laser
- DEVICE Moses 2.0 holmium laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-06 |
| Phase | NA |
What NCT07632742 shows while recruiting
NCT07632742 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Magneto 150 holmium laser is the first listed.
NCT07632742 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07632742 about?
NCT07632742 is a clinical study titled "Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial". The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
What is the current status of trial NCT07632742?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2026-06. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07632742?
The interventions under investigation include: Magneto 150 holmium laser (DEVICE), Moses 2.0 holmium laser (DEVICE).
Who is sponsoring clinical trial NCT07632742?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07632742's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia